Abstract
Although a positive association between type 2 diabetes mellitus (T2DM) and colorectal cancer is well established, uncertainty exists about risk differences in diabetic men and women when considering colorectal neoplasia (CN). The main objective was to examine gender-specific associations of T2DM with CN in a population-based cohort study of adults in Germany. This analysis is based on participants of the ESTHER-study, a population-based cohort study. Participants were 50–74 years old at baseline and underwent colonoscopy during 5 year follow-up. CN detected at colonoscopy were validated by medical records review. Total and gender-specific associations of T2DM at baseline and CN were estimated using log-binomial regression. Overall, 55 cases of CN were detected in 166 participants with T2DM and 328 cases in 1,360 participants without T2DM. In women, CN was found in 32 % of participants with T2DM and in 18 % without T2DM (adjusted prevalence ratio (PR): 1.66 95 % CI 1.04–2.64). In men, prevalence for CN was 35 % for those with T2DM and 33 % for those without T2DM (adjusted PR = 1.01; 95 % CI 0.71–1.43). T2DM might have a stronger impact on CN among women than among men. Further research should examine possible reasons for these differences.
Similar content being viewed by others
Abbreviations
- CN:
-
Colorectal neoplasia
- CRC:
-
Colorectal cancer
- FU1:
-
Follow-up investigations after 2 years
- FU2:
-
Follow-up investigations after 5 years
- HRT:
-
Hormone replacement therapy
- PR:
-
Prevalence ratio
- NSAID:
-
Non-steroidal anti-inflammatory drugs
- T2DM:
-
Type 2 diabetes mellitus
References
GLOBOCAN. Colorectal cancer incidence and mortality worldwide in 2008. Summary [updated 2008; cited 06/07/2010]. Available from: http://globocan.iarc.fr/factsheets/cancers/colorectal.asp. 2008.
Hoffmeister M, Chang-Claude J, Brenner H. Do older adults using NSAIDs have a reduced risk of colorectal cancer? Drugs Aging. 2006;23(6):513–23.
AICR. World cancer research fund /American Institute for cancer research. Washington, DC: Food, nutrition, physical activity and the prevention of cancer: a global perspective; 2007.
Hoffmeister M, Raum E, Krtschil A, et al. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy. Clin Pharmacol Ther. 2009;86(4):416–24.
McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3(8):687–95.
Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6(2):164–79.
Chodick G, Heymann AD, Rosenmann L, et al. Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control. 2010;21(6):879–87.
He J, Stram DO, Kolonel LN, et al. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer. 2010;103(1):120–6.
Khaw KT, Wareham N, Bingham S, et al. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004;13(6):915–9.
Levi F, Pasche C, Lucchini F, et al. Diabetes mellitus, family history, and colorectal cancer. J Epidemiol Community Health. 2002;56(6):479–80.
Lund Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417–22.
Sandhu MS, Luben R, Khaw KT. Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study. J Epidemiol Community Health. 2001;55(11):804–5.
Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care. 2005;28(7):1805–7.
Stürmer T, Buring JE, Lee IM, et al. Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2391–7.
Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91(6):542–7.
Limburg PJ, Anderson KE, Johnson TW, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev. 2005;14(1):133–7.
Flood A, Strayer L, Schairer C, et al. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control. 2010.
Siddiqui AA, Maddur H, Naik S, et al. The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus. Dig Dis Sci. 2008;53(4):1042–7.
Elwing JE, Gao F, Davidson NO, et al. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol. 2006;101(8):1866–71.
Marugame T, Lee K, Eguchi H, et al. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control. 2002;13(10):917–21.
Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200.
Ashbeck EL, Jacobs ET, Martinez ME, et al. Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1134–43.
Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(22):1679–87.
Campbell PT, Deka A, Jacobs EJ, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010;139(4):1138–46.
Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol. 2009;5(10):553–8.
Kang HW, Kim D, Kim HJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol. 2010;105(1):178–87.
Yamamoto S, Nakagawa T, Matsushita Y, et al. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care. 2010;33(1):184–9.
Yamaji T, Iwasaki M, Sasazuki S, et al. Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res. 2010;70(13):5430–7.
Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med 2008; 65(7): 481 (501–486).
Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1688–94.
Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis. 2006;38(9):668–72.
Luchtenborg M, White KK, Wilkens L, et al. Smoking and colorectal cancer: different effects by type of cigarettes? Cancer Epidemiol Biomarkers Prev. 2007;16(7):1341–7.
Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96(10):2992–3003.
Acknowledgments
This study was funded by the State Ministry of Science, Research and Arts of Baden-Württemberg. We very gratefully acknowledge the assistance of our medical documentation office and participation of the study subjects, without them the study would not be possible.
Conflict of interest
All authors have declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krämer, H.U., Müller, H., Stegmaier, C. et al. Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia. Eur J Epidemiol 27, 341–347 (2012). https://doi.org/10.1007/s10654-012-9686-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-012-9686-6